Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2026-01-18 @ 3:07 PM
Study NCT ID:
NCT04260932
Status:
COMPLETED
Last Update Posted:
2022-03-08
First Post:
2020-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients
Sponsor:
Hebei Yanda Ludaopei Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HXYT-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |